中文
Announcement
More
Progress in Chemistry 2007, Vol. 19 Issue (012): 1947-1954 Previous Articles   Next Articles

• Invited Article •

Biocatalysis in Drug Discovery and Development

Chen Yijun* Wu Xuri   

  1. (Laboratory pf Chemical Biology, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China)

  • Received: Revised: Online: Published:
  • Contact: Chen Yijun
PDF ( 2184 ) Cited
Export

EndNote

Ris

BibTeX

Due to the advantages including mild conditions, high catalytic efficiency, high stereoselectivity and regioselectivity and less byproducts, biocatalysis has been widely utilized and applied in drug discovery and development. Moreover, biocatlysts can be structurally changed and optimized through new technologies such as directed evolution, which could be better suited for biocatalytic processes. In this review, recent progress in the field of application of biocatalysis in drug discovery and development is briefly introduced and discussed.

CLC Number: 

[ 1 ] Rozzell D J . Bioorg. Med. Chem. , 1999 , 7 (10) : 2253 —2261
[ 2 ] Wandrey C , Liese A , Kihumbu D. Org. Process Res. Dev. ,2000 , 4 (4) : 286 —290
[ 3 ] Straathof A J , Panke A , Schmid A. Curr. Opin. Biotech. ,2002 , 13 : 548 —556
[ 4 ] Johannes T, Simurdiak M R , Zhao H. Encyclopedia of Chemical Processing , 2006 , 10 : 101 —110
[ 5 ] Faber K. Biotransformation in Organic Chemistry , 4th ed.Germany : Springer-Verlag , 1999. 8 —9
[ 6 ] Michels P C , Khmelnitsky Y L , Dordick J S , et al . Trends Biotechnol . , 1998 , 16 (5) : 210 —215
[ 7 ] Mozhaev V V , Budde C L , Rich J O , et a1. Tetrahedron , 1998 ,54 (16) : 3971 —3982
[ 8 ] De la Géutte J T, Khan A J , Vulfson E N. Biotechnol . Bioeng. ,2001 , 75 (1) : 93 —99
[ 9 ] Fura A , Shu Y Z, Zhu M, et al . J . Med. Chem. , 2004 , 47(18) : 4340 —4351
[10] Norman P , Dihlmann A , Rabasseda X. Drugs Today , 2001 , 37(4) : 215 —227
[11] Benedetti M S , Plisnier M, Kaise J , et al . Eur. J . Pharmacol . ,2001 , 57 (8) : 571 —582
[12] Clissold S P. Drugs , 1986 , 32 (suppl . 4) : 46 —59
[13] Gilman A G, Goodman L S , Rall T W, et al . The Pharmacological Basis of Therapeutics , 7th ed. NY: Macmillan ,1985. 674 —715
[14] Gilman A G, Goodman L S , Rall T W, et al . The Pharmacological Basis of Therapeutics , 7th ed. NY: Macmillan ,1990. 383 —435
[15] Meeves S G, Appajosyula S. J . Allergy Clin. Immunol . , 2003 ,112 (suppl . 4) : 69 —77
[16] Hanson R L , Parker WL , Brzozowski D B , et al . Tetrahedron :Asymmetry , 2005 , 16 (16) : 2711 —2716
[17] Steinreiber A , Faber K. Curr. Opin. Biotech. , 2001 , 12 (6) :552 —558
[18] Goswami A , Totleben M J , Singh A K, et al . Tetrahedron :Asymmetry , 1999 , 10 (16) : 3167 —3175
[19] Patel R N , Howell J M, McNamee C G, et al . Biotechnol . Appl .Biochem. , 1992 , 16 (1) : 34 —47
[20] Campos F , Bosch M P , Guerrero A. Tetrahedron : Asymmetry ,2000 , 11 (13) : 2705 —2717
[21] Hanson R L , Bembenek K S , Patel R N , et al . Appl . Microbiol .Biotechnol . , 1992 , 37 (5) : 599 —603
[22] Hanson R , Schwinden M D , Banerjee A , et al . Bioorg. Med.Chem. , 1999 , 7 (10) : 2247 —2252
[23] Patel R N , Banerjee A , Nanduri V , et al . Enzyme Microb.Technol . , 2000 , 27 (6) : 376 —389
[24] Patel R N. Enzyme Microb. Technol . , 2002 , 31 (6) : 804 —826
[25] Patel R N. Biomol . Eng. , 2001 , 17 (6) : 167 —182
[26] Hanson R , Howell J , LaPorte T, et al . Enzyme Microb.Technol . , 2000 , 26 (5/6) : 348 —358
[27] Bornscheuer U T, Pohl M. Curr. Opin. Chem. Biol . , 2001 , 5(2) : 137 —143
[28] Declerck N , Machius M, Wiegand G, et al . J . Mol . Biol . ,2000 , 301 (4) : 1041 —1057
[29] Annaluru N , Watanabe S , Pack S P , et al . J . Biotechnol . ,2007 , 129 : 717 —722
[30] Sriprapundh D , Vieille C , Zeikus J G. Protein Eng. , 2000 , 13(4) : 259 —265
[31] Kumar S , Tsai C J , Nussinov R. Protein Eng. , 2000 , 13 (3) :179 —191
[32] Pack S P , Yoo Y J . J . Biotechnol . , 2004 , 111 (3) : 269 —277
[33] Terao Y, Ijima Y, Miyamoto K, et al . J . Mol . Catalysis B :Enzymatic , 2007 , 45 (1/2) : 15 —20
[34] Arnold F H. Chem. Eng. Sci . , 1996 , 51 (23) : 5091 —5102
[35] Cadwell R C , Joyce G F. PCR Methods Appl . , 1994 , 3 (6) :136 —140
[36] Stephens D E , Rumbold K, Permaul K, et al . J . Biotechnol . ,2007 , 127 (3) : 348 —354
[37] Stemmer W P C. Nature , 1994 , 370 (6488) : 389 —389
[38] Fortin P D , Macpherson I , Neau D B , et al . J . Biol . Chem. ,2005 , 280 (51) : 42307 —42314
[39] Rosic N N , Huang W, Johnston W A , et al . Gene , 2007 , 395(1/2) : 40 —48

[1] Lujie Song, Youping Wu, Jianping Deng. Enantioselective Release of Chiral Drugs [J]. Progress in Chemistry, 2021, 33(9): 1550-1559.
[2] Andong Hu, Shungui Zhou, Jie Ye. The Mechanism, Progress and Prospect of Biohybrid Mediated Semi-Artificial Photosynthesis [J]. Progress in Chemistry, 2021, 33(11): 2103-2115.
[3] Danbi Tian, Shengnan Wu, Hao Zhang, Ling Jiang, Fengwei Huo. Application of Inner Filter Effect Technology in Biological Detection and Disease Markers [J]. Progress in Chemistry, 2019, 31(2/3): 413-421.
[4] Bin Jia, Yangmin Ma*, Di Chen, Pu Chen, Yan Hu. Studies on Structure and Biological Activity of Indole Diketopiperazine Alkaloids [J]. Progress in Chemistry, 2018, 30(8): 1067-1081.
[5] Dongya Bai, Junyao He, Bin Ouyang, Jin Huang, Pu Wang. Biocatalytic Asymmetric Synthesis of Chiral Aryl Alcohols [J]. Progress in Chemistry, 2017, 29(5): 491-501.
[6] Zhu Yanyan, Ai Chang, Zhang Jia, Zhang Zhengwang, Zhao Changqi. Bioactive Secondary Metabolites from Endophytic Fungi in Plants [J]. Progress in Chemistry, 2011, 23(4): 704-730.
[7] . Synthesis of Chiral Drugs by Titanium-catalyzed Enantioselective Sulfoxidation [J]. Progress in Chemistry, 2010, 22(09): 1760-1766.
[8] . Anti-Plant Pathogenic Fungal Compounds from Endophytic Fungi [J]. Progress in Chemistry, 2010, 22(0203): 440-448.
[9] Ge Huiming|Tan Renxiang**. Symbionts, an Important Source of New Bioactive Natural Products [J]. Progress in Chemistry, 2009, 21(01): 30-46.
[10] Zhang Chun,Zheng yansong**,Mei Fuming,Li Guangxing. Recognition of Bioactive Molecules by Calixarenes [J]. Progress in Chemistry, 2004, 16(06): 934-.